OTCMKTS:TRUMY Terumo (TRUMY) Stock Price, News & Analysis $14.49 +0.06 (+0.43%) As of 12:48 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartEarningsNews and TrendsShort Interest About Terumo Stock (OTCMKTS:TRUMY) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Terumo alerts:Sign Up Key Stats Today's Range$14.46▼$14.5850-Day Range$13.05▼$16.6752-Week Range$12.08▼$18.04Volume20,081 shsAverage Volume254,081 shsMarket Capitalization$21.37 billionP/E Ratio20.40Dividend Yield0.76%Price TargetN/AConsensus RatingBuy Company Overview Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions. Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions. The company also supplies blood management products, including blood bags and automated systems, as well as hospital products such as syringes, infusion systems and injection-related devices. In addition, Terumo develops technologies for therapeutic areas including neurovascular care, aortic treatment and cell and gene therapies. Terumo serves health care providers and patients in Japan and international markets across the Americas, Europe, Asia and other regions. Its products are marketed through a combination of direct operations, subsidiaries and distribution networks, supporting medical professionals in areas including cardiovascular care, blood management and general hospital practice.AI Generated. May Contain Errors. Read More Receive TRUMY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TRUMY Stock News HeadlinesTerumo ADR (TRUMY)September 5, 2026 | es.investing.comTerumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks TranscriptAugust 12, 2026 | seekingalpha.comGold just passed our debt as the world's #1 assetChina's US Treasury holdings have fallen from a peak of $1.32 trillion to roughly $659 billion, an 18-year low. Beijing's central bank has bought gold for 20 straight months, its longest streak in a decade. Goldman Sachs estimates China's real gold buying is 4.8 times the official figure. The European Central Bank confirms gold has overtaken US Treasuries as the world's top reserve asset, at 27% versus 22%. As foreign demand for US debt fades, rates and everyday costs may feel the pressure.September 16 at 1:00 AM | Behind the Markets (Ad)Terumo Corporation (TRUMY) Analyst/Investor Day TranscriptJune 12, 2026 | seekingalpha.comTerumo ADR Stock Price HistoryMay 17, 2026 | investing.comTerumo Corporation (TRUMY) Q4 2026 Earnings Call TranscriptMay 17, 2026 | seekingalpha.comTerumo Corporation (TRUMY) Q3 2026 Earnings Call TranscriptFebruary 13, 2026 | seekingalpha.comTerumo Corporation (TRUMY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 13, 2026 | seekingalpha.comSee More Headlines TRUMY Stock Analysis - Frequently Asked Questions How have TRUMY shares performed this year? Terumo's stock was trading at $14.49 at the beginning of 2026. Since then, TRUMY shares have increased by 0.0% and is now trading at $14.49. How were Terumo's earnings last quarter? Terumo Corp. (OTCMKTS:TRUMY) announced its earnings results on Friday, August, 7th. The company reported $0.30 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.13. The firm had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.84 billion. Terumo had a trailing twelve-month return on equity of 10.44% and a net margin of 13.83%. When did Terumo's stock split? Terumo shares split on the morning of Thursday, March 28th 2024.The 2-1 split was announced on Thursday, March 28th 2024. The newly issued shares were issued to shareholders after the closing bell on Thursday, March 28th 2024. An investor that had 100 shares of stock prior to the split would have 200 shares after the split. How do I buy shares of Terumo? Shares of TRUMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/07/2026Today9/16/2026Next Earnings (Estimated)11/11/2026Fiscal Year End3/31/2027Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryN/A Current SymbolOTCMKTS:TRUMY Previous SymbolNASDAQ:TRUMY CIK1446672 Webwww.terumo.co.jp Phone(133) 374-8111Fax813-3374-8399Employees30,000Year Founded1964Profitability EPS (Trailing Twelve Months)$0.71 Trailing P/E Ratio20.41 Forward P/E Ratio20.70 P/E GrowthN/ANet Income$897.03 million Net Margins13.83% Pretax Margin15.75% Return on Equity10.44% Return on Assets7.34% Debt Debt-to-Equity Ratio0.13 Current Ratio2.19 Quick Ratio1.37 Sales & Book Value Annual Sales$7.52 billion Price / Sales2.84 Cash Flow$1.03 per share Price / Cash Flow14.11 Book Value$7.09 per share Price / Book2.04Miscellaneous Outstanding Shares1,475,070,000Free FloatN/AMarket Cap$21.37 billion OptionableNot Optionable Beta0.68 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:TRUMY) was last updated on 9/16/2026 by MarketBeat.com Staff. From Our PartnersWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredNNVC on Alert: FDA Validation and Outperform Rating!NanoViricides (NYSE: NNVC) just landed FDA Rare Pediatric Disease Designation for NV-387 in Measles, adding to...Equiscreen | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredBlackRock, Vanguard... and a 2.8 million-share buybackManagement just backed a $100 million buyback, repurchasing 2.8 million shares at an average price of $35.26 i...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terumo Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terumo With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRUMY Stock Alerts